Aberrations of the K-ras, p53, and APC genes in extrahepatic bile duct cancer

J Surg Oncol. 2000 Mar;73(3):158-63. doi: 10.1002/(sici)1096-9098(200003)73:3<158::aid-jso9>3.0.co;2-n.

Abstract

Background and objectives: The genetic alterations involved in extrahepatic bile duct (EHBD) cancer are poorly understood. Our aim was to identify aberrations of the K-ras, p53, and APC genes in EHBD cancer.

Methods: We investigated aberrations of these genes in 52 EHBD cancers using polymerase chain reaction (PCR) single-strand conformation polymorphism analysis, followed by direct sequence determination and a PCR restriction fragment length polymorphism assay.

Results: The K-ras, p53, and APC genes were mutated in 9.6%, 32.7%, and 0% of EHBD cancers, respectively. Loss of heterozygosity at the p53 and APC gene loci was identified in 15.6% and 38.5% of EHBD cancers, respectively.

Conclusions: Our results suggest that an unknown suppressor gene on 5q other than the APC gene may be responsible for EHBD cancer.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Bile Duct Neoplasms / genetics*
  • Bile Duct Neoplasms / mortality
  • Bile Duct Neoplasms / pathology
  • Bile Ducts, Extrahepatic*
  • Female
  • Genes, APC / genetics*
  • Genes, p53 / genetics*
  • Genes, ras / genetics*
  • Humans
  • Loss of Heterozygosity
  • Lymphatic Metastasis
  • Male
  • Point Mutation*
  • Polymerase Chain Reaction
  • Polymorphism, Restriction Fragment Length
  • Polymorphism, Single-Stranded Conformational
  • Survival Rate